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Abstract
We present the case of a 3-month-old infant with tetralogy of Fallot (ToF) with pulmonary
artery hypoplasia, critical right ventricle outflow tract (RVOT) obstruction and the presence of
major aortopulmonary collateral arteries (MAPCA) and CATCH 22 syndrome. Due to ana-
tomical conditions (severe pulmonary artery hypoplasia), the patient was not qualified for
palliative operative treatment Blalock-Taussig shunt. We conducted catheterization with an
attempt of balloon plasty and stent implantation into the right ventricle outflow tract and main
pulmonary artery. Successful stent implantation into the right ventricle outflow tract was
performed. The stent created a 4.1 mm diameter channel and allowed for unrestricted blood
flow from the right ventricle to the pulmonary arteries. After the procedure we observed an
increase in blood saturation of up to 89%.
Control echocardiography revealed blood flow through the stent to the pulmonary arteries with
a pressure gradient of 45 mm Hg. There were neither rhythm nor conduction disturbances in
the control ECG after the procedure.
After 6 days of observation the patient was discharged from our department.
We conclude that successful stent implantation into the RVOT in patients with ToF and
hypoplastic pulmonary arteries improves their clinical condition, increases pulmonary blood
flow by physiological means and leads to an improvement of pulmonary artery development
before surgical treatment. (Cardiol J 2008; 15: 376–379)
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Introduction
Tetralogy of Fallot (ToF) is quite a common
congenital heart defect that represents about 6% of
all congenital malformations of the cardiovascular
system. In this condition the presence and degree
of cyanosis depends on right ventricular outflow
tract obstruction and the degree of pulmonary ar-
tery development. Tetralogy of Fallot has many
anatomical variants with different clinical and
hemodynamic findings. The form with correct pul-
monary arteries occurs rarely. Usually a different
degree of pulmonary artery hypoplasia is diagnosed.
A special type of ToF is the form with pulmo-
nary artery hypoplasia, critical right ventricle out-
flow tract (RVOT) obstruction and the presence of
major aortopulmonary collateral arteries (MAPCA).
Blalock-Taussig anastomosis is often the first
step of operative treatment in this type of ToF. It
allows for hypoxia avoidance, satisfactory oxygen
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delivery and pulmonary artery development until
the next step of surgical treatment.
In some patients with severe pulmonary arte-
ry underdevelopment there is no possibility for
systemic-pulmonary anastomosis during the early
life period, and increasing hypoxemia is life-thre-
atening for these children.
Right ventricle outflow tract balloon plasty with
subsequent stent implantation can be an alternati-
ve method of treatment in this group of patients.
We present a case of successful interventional
treatment of a 3-month-old infant with ToF.
Case report
A 2-month-old female infant was admitted to
the Cardiology Department of the Polish Mother’s
Memorial Hospital — Research Institute with a dia-
gnosis of ToF with severe pulmonary artery hypo-
plasia and MAPCAs for preoperative assessment
and qualification for operative treatment. Due to
severe hypoxemia the child required permanent
passive oxygen therapy (arterialized capillary blood
oxygen concentration 70%). The infant was born as
a child from a third pregnancy, full time (41 weeks
of gestation) vaginal delivery with a birth weight of
3680 g and Apgar score of 8 at 5 min.
Cardiac catheterization was performed on the
fifteenth day of life in the Cardiology Department
of the Institute of Pediatrics of the Medical Univer-
sity of Gdansk, where the patient was previously
hospitalized. The catheterization revealed a seve-
re degree of main, right and left pulmonary artery
underdevelopment and 3 big MAPCAs originating
from the descending aorta.
Because of dysmorphia and the type of cardiac
malformation, we suspected CATCH 22 (di George)
syndrome, which was confirmed by FISH test.
Due to anatomical conditions (severe pulmo-
nary hypoplasia) the patient was not qualified for
palliative operative treatment Blalock-Taussig
shunt.
The patient was qualified for recatheterization
with an attempt of balloon plasty and stent implan-
tation into the right ventricle outflow tract and main
pulmonary artery. The body weight at the day of
catheterization was 4500 g.
Method of treatment
After intubation and mechanical ventilation
with 100% oxygen in general anesthesia, a 4 F MPA
catheter (Cordis, Johnson-Johnson) was inserted
into the right ventricle through the right femoral
vein. We then performed angiography which con-
firmed severe right ventricle outflow tract obstruc-
tion with main, right and left pulmonary artery se-
vere underdevelopment. Mean diameter of the main
pulmonary artery was 2.8 mm; right pulmonary ar-
tery — 1.8 mm; and left pulmonary artery — 1.5 mm.
Despite repeated trials, we failed with introduction
of a 0.014” coronary guide wire into the right or left
pulmonary artery. A catheter was introduced into
the right ventricle outflow tract and into the main
pulmonary artery. Using a floppy guide wire (Cor-
dis, Johnson-Johnson) with a 3 cm tip fixed in the
right pulmonary artery we introduced an angiogra-
phic catheter. After stable localisation of the coro-
nary guide wire in the terminal branches of the right
pulmonary artery we introduced a Sprinter corona-
ry balloon catheter 3.5 × 20 mm (Medtronic) and
performed balloon angioplasty of the right ventricle
outflow tract and main and right pulmonary arteries.
We then introduced a coronary stent, fixed on the
balloon Coroflex 3.5 × 16 mm (Braun), into the main
pulmonary artery and after correct fixation in the
space between the RVOT and pulmonary artery bi-
furcation we expanded the balloon with a pressure
of 20 atm. for stent implantation to the RVOT.
We performed control angiography from the
right ventricle and pressure measurements. Anti-
biotic (cephalosporin) was administered prophylac-
tically, and a single dose of heparin (100 U/kg body
weight) was administered during the procedure. In
the days following the procedure the patient was
administered low-molecular-weight heparin (enoxapa-
rin sodium) and we started acetylsalicylate acid treat-
ment (3 mg/kg body weight) with a recommendation
of treatment continuation for 6 months (Fig. 1, 2).
Figure 1. Right ventriculography in a patient with tetra-
logy of Fallot before stent implantation.
RVOT
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Results
Successful stent implantation into the RVOT
was performed. In control angiography we confir-
med correct stent localization from RVOT to
pulmonary artery bifurcation. The stent created
a 4.1 mm diameter channel and allowed for unrestric-
ted blood flow. After the procedure we observed
increase of blood saturation up to 89%.
Control echocardiography revealed blood flow
through the stent to the pulmonary arteries with
a pressure gradient of 45 mm Hg. There were ne-
ither rhythm nor conductivity disturbances in the
control ECG after the procedure.
After 6 days of observation the patient was di-
scharged from our department (Fig. 3).
Discussion
Right ventricle outflow tract and main pulmo-
nary artery stent implantation can be an alternati-
ve to palliative surgical treatment in patients with
ToF and hypoplastic pulmonary arteries, especial-
ly when anatomical conditions restrict surgical tre-
atment. Stent implantation into the RVOT was used
as a method of treatment in patients after surgical
repair with restenosis of native RVOT or implan-
ted homograft [1–3]. This procedure can also be
used in patients with ToF with severe pulmonary
artery underdevelopment despite Blalock-Taussig
anastomosis. In these patients RVOT stent implan-
tation leads to an increase in pulmonary inflow by
anatomical means, blood saturation and improve-
ment of clinical condition [4].
In analyzed publications we did not find any
data concerning coronary stent implantation into the
RVOT in young infants with ToF. The use of a co-
ronary stent was the consequence of the native
pulmonary artery diameter [5]. Such a small stent
diameter may cause internal hypertrophy and stent
occlusion, which occurs in 3–36% of cases [6–8].
Ventricular rhythm disturbances, stent damage,
fracture or dislocation are possible complications of
stent implantation into the RVOT [3].
Outcome
The patient still remains under our observa-
tion. At the age of 8 months (6 months after inte-
rvention) the child was readmitted to our depart-
ment due to cyanosis increase and blood desatura-
tion to 75%. Catheterization revealed a left
pulmonary artery (LPA) diameter of 4 mm and ri-
ght pulmonary artery (RPA) diameter of 3.6 mm.
We also conducted balloon angioplasty on the pre-
viously implanted stent. After intervention, a satu-
ration increase to 85% was observed. The next ca-
theterization, performed at the age of 15 months,
confirmed continuation of pulmonary artery deve-
lopment (LPA 4.2 mm; RPA 3.9 mm); we also
Figure 3. Angiography after deployment of a stent in
the infundibulum, with improvement of blood flow to
the hypoplastic pulmonary arteries; RPA — right pul-
monary artery; LPA — left pulmonary artery.
Figure 2. Angiography from the main pulmonary artery
showed hypoplastic right (RPA) and left (LPA) pulmo-
nary arteries.
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visualized 3 wide MAPCAs originating from the de-
scending aorta. The patient was qualified for surgi-
cal treatment. The right Blalock-Taussig anastomo-
sis (3.5 mm diameter) was performed in the child’s
fifteenth month of age.
During the last hospitalization in November
2007 at the age of 3 years and 2 months, we obse-
rved desaturation to 76–78% and cyanosis increase.
Catheterization visualized critical stenosis of the
right ventricle outflow in the proximal part of the
implanted stent and below the stent. Balloon angio-
plasty with stent Palmaz-Genesis (6 × 18 mm) im-
plantation were performed. We observed a satura-
tion increase to 86% after the intervention.
We have observed systematic development of
the pulmonary arteries from infancy. The diameters
of both pulmonary arteries are currently about 6 mm.
Conclusions
Successful stent implantation into the RVOT
in patients with ToF and hypoplastic pulmonary
arteries improves clinical condition, increases pul-
monary blood flow by physiological means and le-
ads to an improvement in pulmonary artery deve-
lopment before surgical treatment.
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